Adverse drug reactions (ADRs) are a major public health concern, and early detection is
crucial for drug development and patient safety. Together with the increasing availability of …

Adverse drug reaction (ADR) is a common clinical problem, sometimes accompanying with
high risk of mortality and morbidity. It is also one of the major factors that lead to failure in …

Adverse drug reactions (ADRs) are one of the main issues restraining the development and
clinical applications of new drugs. Owing to complicated molecular mechanisms of ADRs …

Drug discovery attrition rates, particularly at advanced clinical trial stages, are high because
of unexpected adverse drug reactions (ADR) elicited by novel drug candidates. Predicting …

Adverse drug reactions (ADRs) are of major concern in drug safety. However, due to the
biological complexity of human systems, understanding the underlying mechanisms …

Adverse drug reactions (ADRs) pose critical public health issues, affecting over 6% of
hospitalized patients. While knowledge of potential drug-drug interactions (DDI) is …

Abstract Background Adverse drug reactions (ADRs) are statistically characterized within
randomized clinical trials and postmarketing pharmacovigilance, but their molecular …

Timely identification of adverse drug reactions (ADRs) is highly important in the domains of
public health and pharmacology. Early discovery of potential ADRs can limit their effect on …

Abstract Adverse Drug Reaction (ADR) is a significant public health concern world-wide.
Numerous graph-based methods have been applied to biomedical graphs for predicting …

Adverse drug reactions (ADRs) are responsible for drug failure in clinical trials and affect life
quality of patients. The identification of ADRs during the early phases of drug development is …